Study to Assess the Efficacy, Safety and Tolerability of LCQ908 in NAFLD Patients
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to determine whether LCQ908 effectively lowers liver fat, as
assessed by MRI and to assess its safety and tolerability profile in subjects with
non-alcoholic fatty liver disease (NAFLD).